Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Pharmacogenomics|July 22, 2026
Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIVZinhle Cindi, Katie M Cardone, Yuki Bradford, et al.
Open Forum Infectious Diseases|December 1, 2025
Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral TherapyTodd Hulgan, Kristine M Erlandson, Yuki Bradford, et al.
The Journal of Infectious Diseases|January 29, 2022
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South AfricaDavid W Haas, Mahmoud Tareq Abdelwahab, Stijn W van Beek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2014
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapyJeffrey M Jacobson, Hongying Wang, Rebeka Bordi, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2016
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)Jose R Castillo-Mancilla, Christina L Aquilante, Michael F Wempe, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2018
Drug metabolism and transport gene polymorphisms and efavirenz adverse effects in Brazilian HIV-positive individualsTailah Bernardo de Almeida, Marcelo Costa Velho Mendes de Azevedo, Jorge Francisco da Cunha Pinto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapyC Bradley Hare, John Mellors, Amy Krambrink, et al.
Clinical Pharmacology and Therapeutics|April 22, 2019
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral TherapyZeruesenay Desta, Roseann S Gammal, Li Gong, et al.
Pageof 19